Active · per the CBE, 29 October 2026

MULTIPHARMA GROUP

BE0401995516

Rechtspersoon Cooperative company 1 establishment

Marie Curiesquare 30, 1070 Anderlecht

Active for

114 year, 3 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Two loss years in a row NBB

    Negative result in 2024 and 2025.

  • Tight liquidity NBB

    Cash and receivables cover 50 % of short-term debt in 2025; threshold 65 %.

  • Busy address KBO

    15 other companies have their registered office at the same address; threshold 10.

  • Not on Peppol Peppol

    Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MULTIPHARMA GROUP from Anderlecht, company number BE0401995516, closed financial year 2025 with a result of € -242,114 after tax. Compared with financial year 2024, the result moved from € -60,057 to € -242,114. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.

What it is worth Growing

€ 164.7 million

▲ 25% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -242,114

▼ 303 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 250,731

▲ 186% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 120.2 million.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 28,585

▲ € 24,835 vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 31 days on average.

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Profit after taxes € -115,388 € 43,818,756 € -60,057 € -242,114 ▼ € 182,057
Equity € 88,497,864 € 131,809,920 € 131,244,162 € 164,699,047 ▲ 25%
Total debts € 527,352 € 527,033 € 522,997 € 1,344,138 ▲ 157%
Cash € 967,389 € 229,037 € 87,566 € 250,731 ▲ 186%
Retained profit € 79,032,939 € 122,344,995 € 121,778,238 € 120,233,123 ▼ 1%
Dividend € 506,700 € 506,700 € 506,700 € 1,303,000 ▲ 157%
Balance sheet total € 89,025,216 € 132,336,953 € 131,767,159 € 166,043,185 ▲ 26%

Key figures of MULTIPHARMA GROUP, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MULTIPHARMA GROUP?

What happened at MULTIPHARMA GROUP in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Gaetane D'HOERAENE stepped down as director. NBB
  • Michel LUTTGENS stepped down as director. NBB
  • Jimmy SCHEVERNELS stepped down as director. NBB
  • Jean-Pierre DI BARTOLOMEO stepped down as director. NBB
  • Johan DEKENS stepped down as director. NBB
  • Martine MAGNEE stepped down as director. NBB
  • Alain THIRION stepped down as director. NBB
  • Julie RICHER stepped down as director. NBB

In short

From € 115,388 loss in 2022 to € 242,114 loss in 2025.

Paid € 7,147 in corporate taxes since 2022.

Best year ever: 2023, with € 43.8 million profit.

Paid out € 2.8 million in dividends to the owners in total.

Management

The shares are held by La maison de la Solidarité V.Z.W. (10%), Financière Botanique S.A. (10%), Vilvo Invest (9.9%), Solidaris Assurance (9.9%), P&V Previdis C.V. (9.9%) and Barsis C.V. (9.9%). It owns 100% of Multipharma C.V. itself.

Directors

According to the 2025 annual accounts

Jean-Paul PHILIPPOT

Director

since 2025 · until 2026

Bart Becks

Director

Also active at: UITGEVERIJ LANNOO, E-HEALTH VENTURE, TIBORED

since 2025 · until 2026

since 2025 · until 2028

Sarah WILLOCKX

Director

Also active at: Belle-Vue, Z-plus

since 2023 · until 2026

Michel LUTTGENS

Director

Also active at: Febecoop

since 2025 · until 2028

Jimmy SCHEVERNELS

Director

since 2025 · until 2028

Hans HEYNDELS

Director

Also active at: Multipharma

since 2024 · until 2027

Mieke VANMARCKE

Director

Also active at: MAISON DE LA SOLIDARITE, Vlaams Socialistisch Gezondheidsfonds, Belle-Vue, I.M.

since 2023 · until 2026

MARC NOPPEN BV

Director

Also active at: Triginta

since 2022 · until 2025

Johan DEKENS

Director

Also active at: HOTEL SPA RESORT, Multipharma

since 2025 · until 2028

Marc DE LAET

Director

Also active at: Autonoom gemeentebedrijf Willebroek

since 2024 · until 2027

Martine MAGNEE

Director

Also active at: Experconsult, BAO Academy, Multipharma

since 2025 · until 2028

Julie RICHER

Director

since 2025 · until 2028

Participations

Establishments

Establishment units

Physical locations of this company

Registered office

Marie Curiesquare 30

1070 Anderlecht

2.012.902.626

Lennikse Baan 900

1070 Anderlecht

Active since 7 September 1901

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0401.995.516
VAT number
BE 0401.995.516
Registered office
Marie Curiesquare 30, 1070 Anderlecht
Names & denominations
MULTIPHARMA GROUP
Enterprise type
Rechtspersoon
Legal form
Cooperative company
Legal situation
Normale toestand
Start date
17 July 1912
Peppol
Not registered

Frequently asked questions

What is the address of MULTIPHARMA GROUP?
The registered office of MULTIPHARMA GROUP is located at Marie Curiesquare 30, 1070 Anderlecht.
Is MULTIPHARMA GROUP still active?
Yes. According to the CBE (29 October 2026) MULTIPHARMA GROUP is active, legal situation “Normale toestand”, started on 17 July 1912.
Is MULTIPHARMA GROUP registered on Peppol?
No, MULTIPHARMA GROUP is currently not registered on the Peppol network.
What is the enterprise number of MULTIPHARMA GROUP?
The enterprise number of MULTIPHARMA GROUP is BE0401995516.
When was MULTIPHARMA GROUP founded?
MULTIPHARMA GROUP was founded on 17 July 1912.
Who owns MULTIPHARMA GROUP?
The shares are held by La maison de la Solidarité V.Z.W. (10%), Financière Botanique S.A. (10%), Vilvo Invest (9.9%), Solidaris Assurance (9.9%), P&V Previdis C.V. (9.9%) and Barsis C.V. (9.9%). It owns 100% of Multipharma C.V. itself.